Capital raise puts Comvita's debt headroom in focus

The effective tax rate was low, at 5.0%, which kept NPAT close to PBT rather than materially eroding it.

Operating cash flow rose 17.9% to $40.26m, and the balance sheet strengthened materially: net debt of $62.4m at FY25 turned into a net cash position of $0.54m, gross borrowings fell 82.5% to $12.5m, and total equity rose 76.4% to $96.8m. Return on equity moved from -191.0% to +7.9%, another sign-crossing swing rather than a growth rate.

Segment mix shows Greater China as the largest contributor (34.6% of revenue, 13.9% gross margin), while North America, the second-largest region at 27.6% of revenue, carries a much thinner 6.6% margin.

Capital raise is explicitly linked in the filing to balance-sheet leverage, with NZ$40.5m capital raised.

The PBT and NPAT turnaround is real in cash and balance-sheet terms, but the current 5.0% effective tax rate is unusually low and its sustainability is untested; investors should treat PBT, the cleaner statutory pre-tax measure here, as the primary read rather than NPAT alone. Comvita's own normalised operating profit measure came in at $16.4m, above the $14.3m normalised EBIT guidance flagged at the half-year mark, which supports an underlying operating improvement narrative.

Cash conversion looks unusually strong. Operating cash flow relative to EBITDA came in at 287.2%, an elevated figure that likely reflects a small EBITDA base rather than an exceptional cash-generation event; this ratio should not be read as a normal recurring conversion rate. Supporting detail is more reassuring: inventory days fell from 168.9 to 136.9 and receivable days fell from 41.2 to 35.8, consistent with inventory normalisation feeding through to cash.

Segment margin mix. With North America now 27.6% of revenue at a 6.6% margin against Greater China's 13.9%, continued growth in the lower-margin region could dilute blended profitability even as top-line growth continues, which matters for anyone assessing margin durability rather than just revenue momentum.

The half-year contributed 55.4% of full-year revenue and 59.3% of full-year NPAT, implying second-half NPAT of roughly $3.2m against a first-half $4.6m — a moderation in profitability into the second half that isn't explained by the release and warrants monitoring given the improved full-year picture.

Part of the improvement looks durable: lower capex intensity (0.6% of revenue, down from 1.7%) and improved inventory and receivable days point to genuine operational tightening rather than one-off timing. Company-defined free cash flow rose from $25.3m to $30.3m, and free cash flow relative to NPAT reached 503.6%, a very high conversion figure that should be read alongside the elevated OCF/EBITDA ratio rather than in isolation — both suggest the current EBITDA base is small relative to cash generated, not necessarily that cash quality has structurally improved to this degree. The absence of a disclosed EBITDA figure limits full corroboration of these ratios as clean operating-margin evidence.

This briefing cannot assess the sustainability of the low effective tax rate or the underlying EBITDA base used in the cash-conversion ratios, since neither was independently disclosed in the supplied data.